PAGP250117P11000
- 0.00
- 0.000.00%
Plains GP Holdings Newsroom
Plains GP Holdings Is Maintained at Underweight by Barclays
Barclays Maintains Plains GP Holdings(PAGP.US) With Sell Rating, Maintains Target Price $19
Barclays Maintains Plains GP Holdings(PAGP.US) With Sell Rating, Raises Target Price to $19
Barclays Remains a Sell on Plains GP Holdings (PAGP)
Plains GP Holdings Raised to Outperform From Peer Perform by Wolfe Research
Plains GP Holdings Analyst Ratings
Wolfe Research Upgrades Plains GP Holdings(PAGP.US) to Buy Rating, Announces Target Price $22
Wolfe Research Upgrades Plains GP Holdings (PAGP) to a Buy
Plains GP Holdings Cut to Equal-Weight From Overweight by Wells Fargo
Plains GP Holdings Analyst Ratings
Wells Fargo Downgrades Plains GP Holdings(PAGP.US) to Hold Rating, Maintains Target Price $20
Truist Financial Maintains Plains GP Holdings(PAGP.US) With Buy Rating
Stifel Maintains Plains GP Holdings(PAGP.US) With Buy Rating, Maintains Target Price $23
Plains GP Holdings Analyst Ratings
Morgan Stanley Downgrades Plains GP Holdings(PAGP.US) to Hold Rating, Cuts Target Price to $19
Goldman Sachs Initiates Plains GP Holdings(PAGP.US) With Sell Rating, Announces Target Price $17
Barclays Maintains Plains GP Holdings(PAGP.US) With Sell Rating, Maintains Target Price $18
Morgan Stanley Maintains Plains GP Holdings(PAGP.US) With Buy Rating, Raises Target Price to $22
Plains GP Holdings (PAGP) Gets a Buy From Morgan Stanley
Barclays Maintains Plains GP Holdings(PAGP.US) With Sell Rating, Maintains Target Price $18